SCHEMBL15764740

SCHEMBL15764740

Cc1ccc(C(=O)N(CCCNO)C(c2nc3cc(Cl)ccc3c(=O)n2Cc2ccccc2)C(C)C)cc1

nearest known ligand 0.83

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 7/20 0.83
MAP1LC3B Q9GZQ8 3/20 0.83
CYP3A4 P08684 1/20 0.83
CYP2C19 P33261 1/20 0.83
KCNH2 Q12809 1/20 0.83
PDE6D O43924 4/20 0.65
KIF23 Q02241 1/20 0.55
NAMPT P43490 7/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16096544 0.94 KIF11 (0.83) KIF11MAP1LC3BCYP3A4CYP2C19KCNH2
SCHEMBL14264772 0.92 KIF11 (0.87) KIF11MAP1LC3BCYP3A4CYP2C19KCNH2
Ispinesib SCHEMBL3582165 0.91 KIF11 (1.00) KIF11MAP1LC3BCYP3A4CYP2C19KCNH2
Ispinesib SCHEMBL29375933 0.91 KIF11 (1.00) KIF11MAP1LC3BCYP3A4CYP2C19KCNH2
Ispinesib SCHEMBL370194 0.91 KIF11 (1.00) KIF11MAP1LC3BCYP3A4CYP2C19KCNH2
Ispinesib SCHEMBL15810599 0.91 KIF11 (1.00) KIF11MAP1LC3BCYP3A4CYP2C19KCNH2
SCHEMBL23964533 0.91 KIF11 (0.78) KIF11MAP1LC3BCYP3A4CYP2C19KCNH2
SCHEMBL28932777 0.91 KIF11 (0.78) KIF11MAP1LC3BCYP3A4CYP2C19KCNH2
SCHEMBL6353088 0.90 KIF11 (0.77) KIF11MAP1LC3BCYP3A4CYP2C19KCNH2
Ispinesib SCHEMBL29711229 0.89 KIF11 (1.00) KIF11MAP1LC3BCYP3A4CYP2C19KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014085575-A1 METHODS FOR TREATING CANCER USING COMBINATION THERAPIES ENDOCYTE, INC. (US) 2014-06-05 WO disclosed
WO-2009002993-A1 CONJUGATES CONTAINING HYDROPHILIC SPACER LINKERS ENDOCYTE, INC. (US) 2008-12-31 WO disclosed